free-downloads CSEVideos


2016-2017 Influenza Antiviral Recommendations

Discussion in 'General Discussion' started by Ghada Ali youssef, Jan 14, 2017.

  1. Ghada Ali youssef

    Ghada Ali youssef Golden Member

    Joined:
    Dec 29, 2016
    Messages:
    2,490
    Likes Received:
    91
    Trophy Points:
    4,175
    Gender:
    Female
    Practicing medicine in:
    Egypt

    Today I'll be discussing influenza antiviral medications and reviewing CDC's recommendations for the treatment of influenza. However, I want to begin by emphasizing that vaccination remains the most important influenza prevention tool. CDC recommends ongoing vaccination as long as influenza viruses are circulating, so please continue to vaccinate your patients as you see them over the course of the season. Your recommendation and offer of vaccination are a tremendous motivator to patients.

    While influenza is unpredictable, laboratory data suggest that influenza A (H3N2) viruses are predominating during the 2016-17 season. Influenza A (H3N2)–predominant seasons often are associated with more severe illness, especially in young children and older adults. While serious influenza complications can occur in people of any age, certain people are at greater risk for complications, including pregnant women, adults aged 65 or older, children younger than 2 years of age, and people with underlying health conditions like immunosuppression, asthma, diabetes, or heart disease. Influenza vaccination—and treatment—among high-risk patients is critical.

    Influenza antiviral medications are an important adjunct to vaccination. While any person can be treated with influenza antivirals, CDC recommends rapid empiric treatment of high-risk persons with influenza symptoms. Clinical judgment, on the basis of the patient's disease severity and progression, age, underlying medical conditions, likelihood of influenza, and time since onset of symptoms, is important when making antiviral treatment decisions for high-risk outpatients.

    Antiviral treatment is also recommended as early as possible for any patient with confirmed or suspected influenza who is hospitalized or who has severe, complicated, or progressive illness. A recent study has shown that among hospitalized patients with laboratory-confirmed influenza, antiviral treatment increased from 72% in 2010-11 to 89% in the 2014-15 season.Antiviral Guidance References.

    The three prescription antiviral medications recommended for treatment of influenza are oral oseltamivir, inhaled zanamivir, and intravenous peramivir. These neuraminidase inhibitors are chemically related and have activity against both influenza A and B viruses. Generic oseltamivir was approved by the US Food and Drug Administration (FDA) in August 2016 and became available in December. FDA Approves First Generic Tamiflu.

    To treat influenza, oral oseltamivir and inhaled zanamivir are usually prescribed for 5 days, although hospitalized patients may receive treatment for longer. Intravenous peramivir is administered in a single infusion over 15-30 minutes. Peramivir is approved for treatment in adults, zanamivir for treatment of children 7 years or older, and oseltamivir for treatment even in infants. Antiviral dosage information for different age groups is available at CDC's Influenza Antiviral Medications: Summary for Clinicians webpage.

    Antiviral resistance among circulating influenza viruses to any of the neuraminidase inhibitor antiviral drugs is currently low, but rare, sporadic cases of antiviral resistance can occur. CDC publishes weekly surveillance data, including information on antiviral resistance, in the FluView US Influenza Surveillance Report.

    To close, I will remind you once again that vaccination remains the most important step to prevent influenza, and antiviral medications can be a useful second line of defense to treat influenza illness when indicated. Please see the CDC website for complete guidance on treatment of influenza.

    bccbcdd3c3f4f6e8b82754a5c121f86b.jpg

    Thank you.

    Source
     

    Add Reply
    Last edited: Jan 14, 2017

Share This Page

<